Table 3.
Univariate | Multivariate | ||||
---|---|---|---|---|---|
Variable | HR(95% CI) | P value | HR(95% CI) | P value | |
Age (≤60 years vs. > 60 years) | 1.154(0.806-1.653) | 0.435 | |||
Sex (male vs. female) | 0.939(0.650-1.357) | 0.939 | |||
Primary tumor location (colon vs. rectum) | 1.880(1.247-2.835) | 0.003 | 1.022(0.665-1.571) | 0.921 | |
Tumor size (>5 cm vs. ≤5 cm) | 0.700(0.465-1.055) | 0.088 | |||
Primary tumor differentiation (poor vs. well to moderate) | 1.549(0.996-2.408) | 0.052 | |||
TNM stage (IV vs. II-III) | 6.043(3.937-9.277) | <0.001 | 5.447(3.475-8.538) | <0.001 | |
Preoperative CEA (>5 ng/ml vs. ≤ 5 ng/ml) | 2.653(1.774-3.967) | <0.001 | 1.610(1.043-2.485) | 0.032 | |
Preoperative CA199 (>35 U/ml vs. ≤ 35 U/ml) | 2.984(2.071-4.298) | <0.001 | 2.134(1.433-3.178) | <0.001 | |
Adjuvant chemotherapy (yes vs. no) | 0.838(0.570-1.232) | 0.369 | |||
NDRG2 expression (low vs. high) | 1.550(1.077-2.232) | 0.018 | 1.499(1.037-2.165) | 0.031 |
Abbreviations: HRs: hazard ratios, CI: confidence interval, TNM stage: tumor-node-metastasis classification, CEA: carcinoembryonic antigen, CA19-9: carbohydrate antigen 19-9